Lixin Fu

1.1k total citations
39 papers, 536 citations indexed

About

Lixin Fu is a scholar working on Immunology, Molecular Biology and Dermatology. According to data from OpenAlex, Lixin Fu has authored 39 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Molecular Biology and 10 papers in Dermatology. Recurrent topics in Lixin Fu's work include Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (5 papers) and T-cell and B-cell Immunology (5 papers). Lixin Fu is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (5 papers) and T-cell and B-cell Immunology (5 papers). Lixin Fu collaborates with scholars based in China, United States and Japan. Lixin Fu's co-authors include Lei Xi, Kexin Sun, Manran Liu, Dan Yang, Yixuan Hou, Yilu Qin, Siyang Wen, Maojia Zhao, Yong Teng and Tao Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Lixin Fu

35 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixin Fu China 11 226 174 171 112 62 39 536
Guo‐Kang Fan China 15 237 1.0× 213 1.2× 75 0.4× 92 0.8× 57 0.9× 28 559
Shen‐Wu Wang China 11 274 1.2× 124 0.7× 179 1.0× 89 0.8× 113 1.8× 20 638
Xinsheng Xie China 15 370 1.6× 171 1.0× 167 1.0× 151 1.3× 99 1.6× 72 726
Jasminka Jakić‐Razumović Croatia 16 199 0.9× 214 1.2× 93 0.5× 112 1.0× 74 1.2× 69 639
Gefei Qing Canada 16 233 1.0× 88 0.5× 246 1.4× 56 0.5× 171 2.8× 32 649
Robert Saddawi‐Konefka United States 13 207 0.9× 299 1.7× 431 2.5× 54 0.5× 83 1.3× 32 774
Yongpeng Gu United States 9 276 1.2× 343 2.0× 257 1.5× 99 0.9× 163 2.6× 12 755
Xinhua Zhu China 13 163 0.7× 104 0.6× 90 0.5× 53 0.5× 68 1.1× 59 487
Yoichi Ohiro Japan 12 262 1.2× 151 0.9× 77 0.5× 109 1.0× 72 1.2× 51 576
Jubilee B. Robinson United States 8 194 0.9× 147 0.8× 81 0.5× 133 1.2× 59 1.0× 10 563

Countries citing papers authored by Lixin Fu

Since Specialization
Citations

This map shows the geographic impact of Lixin Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin Fu more than expected).

Fields of papers citing papers by Lixin Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixin Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin Fu. The network helps show where Lixin Fu may publish in the future.

Co-authorship network of co-authors of Lixin Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Lixin Fu. A scholar is included among the top collaborators of Lixin Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixin Fu. Lixin Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Lixin, et al.. (2023). Varicella‐zoster virus infection and primary membranous nephropathy: a Mendelian randomization study. Scientific Reports. 13(1). 19212–19212. 3 indexed citations
2.
Zhang, Liwen, et al.. (2023). Psoriasiform lesions induced by anti-PD-1 antibody. European Journal of Dermatology. 33(2). 179–181.
3.
Fu, Lixin, et al.. (2022). Mendelian randomization study of the genetic interaction between psoriasis and celiac disease. Scientific Reports. 12(1). 21508–21508. 5 indexed citations
4.
Zhang, Li‐wen, et al.. (2022). Disseminated herpes zoster following inactivated SARS-CoV-2 vaccine in a healthy old man. European Journal of Dermatology. 32(3). 415–416. 3 indexed citations
5.
Li, Xin, Jie Yu, Yan Zhao, et al.. (2022). Isoxanthanol has protective and anti-inflammatory effects on subchondral bone deterioration in experimental osteoarthritic rat model. Acta Biochimica Polonica. 69(1). 65–69. 1 indexed citations
6.
Fu, Lixin, et al.. (2021). Dermoscopy Features of Acquired Perforating Dermatosis Among 39 Patients. Frontiers in Medicine. 8. 631642–631642. 4 indexed citations
7.
Fu, Lixin, et al.. (2021). Interleukin-35 inhibited the production of histamine and pro-inflammatory cytokines through suppression MAPKs pathway in HMC-1 cells. Allergy Asthma and Clinical Immunology. 17(1). 38–38. 6 indexed citations
8.
Fu, Lixin, et al.. (2021). Enhanced serum interferon-lambda 1/interleukin-29 levels in patients with psoriasis vulgaris. Anais Brasileiros de Dermatologia. 96(4). 416–421. 9 indexed citations
9.
Ibañez, David P., Wenxia Fan, Ping Zhao, et al.. (2020). Generation of an induced pluripotent stem cell line (GIBHi004-A) from a Parkinson’s disease patient with mutant DJ-1/PARK7 (p.L10P). Stem Cell Research. 46. 101845–101845. 2 indexed citations
10.
Fu, Lixin, et al.. (2020). Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis. PLoS ONE. 15(9). e0239586–e0239586. 21 indexed citations
11.
Fu, Lixin, Li‐wen Zhang, Dawei Zhang, et al.. (2020). Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice. Archives of Dermatological Research. 312(7). 481–490. 8 indexed citations
12.
Zhang, Li‐wen, Yonghong Lu, Conghui Li, et al.. (2019). Erythema papulatum centrifugum and new diagnostic criteria. Australasian Journal of Dermatology. 61(1). e87–e90.
13.
Zhang, Li‐wen, et al.. (2019). A case of linear atrophoderma of Moulin. Anais Brasileiros de Dermatologia. 95(1). 119–121. 1 indexed citations
14.
Zhang, Li‐wen, et al.. (2018). Appearance of prominent milia as secondary lesions during recovery of refractory bullous pemphigoid: a case report. International Journal of Dermatology and Venereology. 1(4). 253–255.
16.
Fan, Jun, Yi Zhang, Jue Zhang, et al.. (2018). Establishment of a time-resolved fluoroimmunoassay in detection of human epidermal growth factor receptor 2. 38(5). 336–339. 1 indexed citations
17.
Lang, Lei, Yixuan Hou, Yanlin Chen, et al.. (2018). ATM-Mediated Phosphorylation of Cortactin Involved in Actin Polymerization Promotes Breast Cancer Cells Migration and Invasion. Cellular Physiology and Biochemistry. 51(6). 2972–2988. 19 indexed citations
18.
Yan, Hengxiu, Weiwei Li, Yan Zhang, et al.. (2014). Accumulation of FLT3+ CD11c+ dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor. Immunologic Research. 60(1). 112–126. 12 indexed citations
19.
Yan, Hengxiu, Ping Cheng, Haiyan Wei, et al.. (2013). Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2. Oncology Reports. 29(4). 1510–1516. 20 indexed citations
20.
Yan, Hengxiu, et al.. (2013). A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis. Molecular Medicine Reports. 8(2). 434–438. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026